Omada Health, Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 |
|---|---|---|---|
| Revenue | $260.2M | $169.8M | $122.8M |
| Gross profit | $170.9M | $102.9M | $70.0M |
| Operating income | -$12.0M | -$43.7M | -$66.0M |
| Operating expenses | $182.9M | $146.5M | $136.0M |
| Cost of revenue | $89.3M | $66.9M | $52.8M |
| Cash from operations | $18.3M | -$34.2M | -$49.7M |
| Capital expenditure | $1.3M | $596,000 | $416,000 |
| Free cash flow | $16.9M | -$34.8M | -$50.2M |
| Impairments | $0 | $0 | $0 |
| Total assets | $305.4M | $150.9M | — |
| Total liabilities | $75.7M | $86.3M | — |
Shares outstanding 59.4M · Free float 91.9%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.